Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

FDA Approves Pfizer’s Pneumococcal 20-valent Conjugate Vaccine For Adults

The U.S. Food and Drug Administration has approved Pfizer Inc.'s (PFE) PREVNAR 20 or Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae or pneumococcus serotypes in the vaccine in adults ages 18 years and older.

Ministry of Health of the Russian Federation issues permit for post-registration trials of CoviVac

The Russian Health Ministry has issued a permit to conduct the post-registration clinical trials of the CoviVac shot against the coronavirus infection with the...

R-Pharm and Beijing Health Guard entered into collaboration agreements of a HPV vaccine

The agreements provide for the conduct of phase III clinical trials and registration of the nonavalent HPV vaccine in Russia.

East-Pharm to Choose Kaluga SEZ

East-Pharm is a modern Russian high-tech pharmaceutical company specializing in the production of infusion solutions in accordance with GMP.

New productions to be created at Microgen

Pharmaceutical holding Nacimbio of Rostec State Corporation will create new production facilities at NPO Microgen subsidiaries in Ufa, Perm and Tomsk. Biotechnology products, including...

RDIF and Sanofi to develop digital healthcare solutions in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Sanofi, one of the leading global pharmaceutical companies, agree to cooperate for joint...
spot_img

Expert Articles

spot_img